3 ms·
The issue is more the licensing and initial inspections rather than actual production. And I'm a big fan of these inspections. As bad as some of our prescrip
by monocasa 9y ago
The issue is more the licensing and initial inspections rather than actual production.
And I'm a big fan of these inspections. As bad as some of our prescription distribution is, it's nothing compared to India/China and their customer nations. You're borderline lucky to get the right drug, that's been manufactured to spec, and has been stored properly.